MedPath

Cranberry (Poly)Phenol Consumption on Vascular Function

Not Applicable
Completed
Conditions
Healthy Young
Interventions
Dietary Supplement: cranberry (poly)phenol containing supplement
Registration Number
NCT02764749
Lead Sponsor
Heinrich-Heine University, Duesseldorf
Brief Summary

Epidemiological studies suggest that the consumption of (poly)phenols rich foods such as cocoa, tea, fruits and vegetables is associated with lower blood pressure, reduced cholesterol and decreased cardiovascular risk. Cranberries are a rich source of (poly)phenols, including anthocyanins, proanthocyanidins and phenolic acids. Whether cranberries can improve vascular function when given over relevant time periods and in relevant populations is not known. Therefore, it is the overall hypothesis of the study proposal that chronic consumption of cranberries can improve endothelial function, a prognostically validated surrogate of cardiovascular risk. This study also aims to reveal which cranberry (poly)phenols have bioactive properties in healthy men. Consequently, plasma and urine metabolite peaks will be correlated with vascular outcomes and genome-wide expression microarrays will be performed to reveal cell signaling pathways associated with cranberry (poly)phenol-mediated cardioprotective events.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • healthy male subjects (no clinical signs or symptoms of CVD)
  • Young >18 years, <35 years
Exclusion Criteria
  • CVD
  • acute inflammation
  • cardiac arrhythmia
  • renal failure
  • heart failure (NYHA II-IV)
  • diabetes mellitus
  • CRP > 1 mg/dl
  • malignant disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
freeze dried powder whole cranberry dissolved in watercranberry (poly)phenol containing supplementDietary Supplement: freeze dried cranberry powder
Primary Outcome Measures
NameTimeMethod
Change form Baseline Endothelial function at 1 month2 hours and 1 month

Measured by Flow mediated dilation (FMD)

Secondary Outcome Measures
NameTimeMethod
Pulse wave velocityBaseline and 1 month

Measured by SphygmoCor 0 and 2 hours postconsumption

Blood pressureBaseline and 1month

automatical measurements 0 and 2 hours postconsumption

high density lipoproteins (HDL)Baseline and 1 month

measured on baseline and after 1 month

low density lipoproteins (LDL)Baseline and 1 month

measured on baseline and after 1 month

triglycerideBaseline and 1 month

measured on baseline and after 1 month

Trial Locations

Locations (1)

Division of Cardiology, Pulmonary Disease and Vascular Medicine, University Hospital Duesseldorf

🇩🇪

Duesseldorf, Germany

© Copyright 2025. All Rights Reserved by MedPath